Alnylam Pharmaceuticals Inc. (ALNY)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Greenstreet Officer, Director	$256.29	98	$25,116.42	81,784	2025-02-14	Filing
Greenstreet Officer, Director	$255.56	85	$21,722.60	81,882	2025-02-14	Filing
Greenstreet Officer, Director	$254.35	201	$51,124.35	81,967	2025-02-14	Filing
Greenstreet Officer, Director	$253.37	300	$76,011.00	82,168	2025-02-14	Filing
Greenstreet Officer, Director	$252.50	271	$68,427.50	82,468	2025-02-14	Filing
Poulton Officer	$264.87	20	$5,297.40	32,786	2025-02-14	Filing
Poulton Officer	$263.33	17	$4,476.61	32,806	2025-02-14	Filing
Poulton Officer	$261.45	37	$9,673.65	32,823	2025-02-14	Filing
Poulton Officer	$260.57	30	$7,817.10	32,860	2025-02-14	Filing
Poulton Officer	$259.72	17	$4,415.24	32,890	2025-02-14	Filing
Poulton Officer	$258.07	47	$12,129.29	32,907	2025-02-14	Filing
Poulton Officer	$257.51	37	$9,527.87	32,954	2025-02-14	Filing
Poulton Officer	$256.29	78	$19,990.62	32,991	2025-02-14	Filing
Poulton Officer	$255.56	68	$17,378.08	33,069	2025-02-14	Filing
Poulton Officer	$254.35	160	$40,696.00	33,137	2025-02-14	Filing
Poulton Officer	$253.37	239	$60,555.43	33,297	2025-02-14	Filing
Poulton Officer	$252.50	217	$54,792.50	33,536	2025-02-14	Filing
Fitzgerald Officer	$259.10	83	$21,505.30	12,881	2025-02-18	Filing
Fitzgerald Officer	$257.79	76	$19,592.04	12,964	2025-02-18	Filing
Fitzgerald Officer	$256.05	80	$20,484.00	13,040	2025-02-18	Filing